nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Cladribine—multiple sclerosis	0.0753	0.116	CbGbCtD
Buprenorphine—ABCG2—Mitoxantrone—multiple sclerosis	0.0549	0.0845	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—multiple sclerosis	0.0522	0.0802	CbGbCtD
Buprenorphine—CYP2D6—Fingolimod—multiple sclerosis	0.0397	0.061	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—multiple sclerosis	0.0308	0.0473	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—multiple sclerosis	0.0285	0.0438	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—multiple sclerosis	0.0271	0.0417	CbGbCtD
Buprenorphine—CYP3A4—Fingolimod—multiple sclerosis	0.0252	0.0388	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—multiple sclerosis	0.0229	0.0352	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—multiple sclerosis	0.021	0.0323	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.021	0.0323	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—multiple sclerosis	0.0204	0.0313	CbGbCtD
Buprenorphine—ABCB1—Mitoxantrone—multiple sclerosis	0.0198	0.0305	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—multiple sclerosis	0.0176	0.0271	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—multiple sclerosis	0.0174	0.0268	CbGbCtD
Buprenorphine—ABCB1—Prednisone—multiple sclerosis	0.0164	0.0253	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0163	0.025	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—multiple sclerosis	0.0158	0.0243	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—multiple sclerosis	0.0152	0.0233	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—multiple sclerosis	0.0127	0.0196	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—multiple sclerosis	0.0123	0.019	CbGbCtD
Buprenorphine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0119	0.0182	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—multiple sclerosis	0.0106	0.0163	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—multiple sclerosis	0.0106	0.0163	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—multiple sclerosis	0.0104	0.016	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—multiple sclerosis	0.0103	0.0158	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—multiple sclerosis	0.00985	0.0152	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—multiple sclerosis	0.00967	0.0149	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—multiple sclerosis	0.00825	0.0127	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—multiple sclerosis	0.00615	0.00946	CbGbCtD
Buprenorphine—Naloxone—TLR4—multiple sclerosis	0.0035	0.889	CrCbGaD
Buprenorphine—OPRL1—brainstem—multiple sclerosis	0.0017	0.112	CbGeAlD
Buprenorphine—OPRM1—nerve—multiple sclerosis	0.00139	0.0919	CbGeAlD
Buprenorphine—OPRL1—spinal cord—multiple sclerosis	0.00106	0.0698	CbGeAlD
Buprenorphine—OPRL1—nervous system—multiple sclerosis	0.000891	0.0588	CbGeAlD
Buprenorphine—OPRL1—central nervous system—multiple sclerosis	0.000858	0.0566	CbGeAlD
Buprenorphine—OPRL1—brain—multiple sclerosis	0.000681	0.045	CbGeAlD
Buprenorphine—OPRM1—brainstem—multiple sclerosis	0.000598	0.0394	CbGeAlD
Buprenorphine—OPRD1—nervous system—multiple sclerosis	0.000459	0.0303	CbGeAlD
Buprenorphine—OPRD1—central nervous system—multiple sclerosis	0.000442	0.0292	CbGeAlD
Buprenorphine—OPRK1—nervous system—multiple sclerosis	0.00044	0.029	CbGeAlD
Buprenorphine—Naloxone—ALB—multiple sclerosis	0.000437	0.111	CrCbGaD
Buprenorphine—OPRK1—central nervous system—multiple sclerosis	0.000424	0.028	CbGeAlD
Buprenorphine—OPRK1—cerebellum—multiple sclerosis	0.000414	0.0273	CbGeAlD
Buprenorphine—OPRM1—midbrain—multiple sclerosis	0.000381	0.0251	CbGeAlD
Buprenorphine—OPRM1—spinal cord—multiple sclerosis	0.000372	0.0245	CbGeAlD
Buprenorphine—OPRD1—brain—multiple sclerosis	0.000351	0.0232	CbGeAlD
Buprenorphine—OPRK1—brain—multiple sclerosis	0.000336	0.0222	CbGeAlD
Buprenorphine—CYP2A6—cerebellum—multiple sclerosis	0.000316	0.0208	CbGeAlD
Buprenorphine—OPRM1—nervous system—multiple sclerosis	0.000313	0.0207	CbGeAlD
Buprenorphine—OPRM1—central nervous system—multiple sclerosis	0.000301	0.0199	CbGeAlD
Buprenorphine—CYP2A6—brain—multiple sclerosis	0.000256	0.0169	CbGeAlD
Buprenorphine—ABCG2—medulla oblongata—multiple sclerosis	0.000244	0.0161	CbGeAlD
Buprenorphine—CYP2D6—brainstem—multiple sclerosis	0.00024	0.0158	CbGeAlD
Buprenorphine—OPRM1—brain—multiple sclerosis	0.000239	0.0158	CbGeAlD
Buprenorphine—ABCG2—midbrain—multiple sclerosis	0.000223	0.0147	CbGeAlD
Buprenorphine—ABCG2—spinal cord—multiple sclerosis	0.000217	0.0143	CbGeAlD
Buprenorphine—ABCG2—cerebellum—multiple sclerosis	0.000172	0.0114	CbGeAlD
Buprenorphine—ABCB1—retina—multiple sclerosis	0.000166	0.011	CbGeAlD
Buprenorphine—Insomnia—Prednisolone—multiple sclerosis	0.000159	0.000752	CcSEcCtD
Buprenorphine—Shock—Methylprednisolone—multiple sclerosis	0.000159	0.000751	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000159	0.000749	CcSEcCtD
Buprenorphine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000159	0.000748	CcSEcCtD
Buprenorphine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000158	0.000747	CcSEcCtD
Buprenorphine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000158	0.000747	CcSEcCtD
Buprenorphine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000158	0.000747	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—multiple sclerosis	0.000158	0.000747	CcSEcCtD
Buprenorphine—Tachycardia—Triamcinolone—multiple sclerosis	0.000158	0.000746	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—multiple sclerosis	0.000158	0.000745	CcSEcCtD
Buprenorphine—Nausea—Azathioprine—multiple sclerosis	0.000158	0.000745	CcSEcCtD
Buprenorphine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000158	0.000745	CcSEcCtD
Buprenorphine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000157	0.000741	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—multiple sclerosis	0.000157	0.00074	CcSEcCtD
Buprenorphine—Erythema—Prednisone—multiple sclerosis	0.000157	0.00074	CcSEcCtD
Buprenorphine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000157	0.000739	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000156	0.000738	CcSEcCtD
Buprenorphine—Convulsion—Betamethasone—multiple sclerosis	0.000156	0.000737	CcSEcCtD
Buprenorphine—Convulsion—Dexamethasone—multiple sclerosis	0.000156	0.000737	CcSEcCtD
Buprenorphine—Hypertension—Dexamethasone—multiple sclerosis	0.000156	0.000734	CcSEcCtD
Buprenorphine—Hypertension—Betamethasone—multiple sclerosis	0.000156	0.000734	CcSEcCtD
Buprenorphine—Asthenia—Mitoxantrone—multiple sclerosis	0.000154	0.000727	CcSEcCtD
Buprenorphine—Myalgia—Dexamethasone—multiple sclerosis	0.000153	0.000724	CcSEcCtD
Buprenorphine—Myalgia—Betamethasone—multiple sclerosis	0.000153	0.000724	CcSEcCtD
Buprenorphine—Anxiety—Betamethasone—multiple sclerosis	0.000153	0.000721	CcSEcCtD
Buprenorphine—Anxiety—Dexamethasone—multiple sclerosis	0.000153	0.000721	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—multiple sclerosis	0.000152	0.000715	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—multiple sclerosis	0.000152	0.000715	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—multiple sclerosis	0.000151	0.000713	CcSEcCtD
Buprenorphine—Pain—Prednisolone—multiple sclerosis	0.000151	0.000711	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—multiple sclerosis	0.00015	0.000706	CcSEcCtD
Buprenorphine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000149	0.000702	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—multiple sclerosis	0.000148	0.000698	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—multiple sclerosis	0.000148	0.000697	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000148	0.000697	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000147	0.000695	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Buprenorphine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—multiple sclerosis	0.000147	0.000692	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—multiple sclerosis	0.000146	0.00069	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—multiple sclerosis	0.000146	0.000689	CcSEcCtD
Buprenorphine—Infection—Betamethasone—multiple sclerosis	0.000146	0.000689	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000146	0.000687	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000146	0.000687	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000145	0.000685	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000145	0.000685	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—multiple sclerosis	0.000145	0.000685	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—multiple sclerosis	0.000145	0.000683	CcSEcCtD
Buprenorphine—Shock—Betamethasone—multiple sclerosis	0.000145	0.000683	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000145	0.000682	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000144	0.000681	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000144	0.000681	CcSEcCtD
Buprenorphine—Agitation—Prednisone—multiple sclerosis	0.000144	0.00068	CcSEcCtD
Buprenorphine—CYP2C8—brain—multiple sclerosis	0.000144	0.0095	CbGeAlD
Buprenorphine—Tachycardia—Dexamethasone—multiple sclerosis	0.000144	0.000677	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—multiple sclerosis	0.000144	0.000677	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—multiple sclerosis	0.000143	0.000677	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000143	0.000673	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000142	0.000672	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000142	0.000671	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000142	0.000671	CcSEcCtD
Buprenorphine—Malaise—Prednisone—multiple sclerosis	0.000142	0.000668	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—multiple sclerosis	0.000141	0.000665	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—multiple sclerosis	0.000141	0.000664	CcSEcCtD
Buprenorphine—Syncope—Prednisone—multiple sclerosis	0.000141	0.000664	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—multiple sclerosis	0.000141	0.000663	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—multiple sclerosis	0.00014	0.000661	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—multiple sclerosis	0.00014	0.000661	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—multiple sclerosis	0.00014	0.000661	CcSEcCtD
Buprenorphine—ABCG2—brain—multiple sclerosis	0.00014	0.00924	CbGeAlD
Buprenorphine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00014	0.00066	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—multiple sclerosis	0.00014	0.000659	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—multiple sclerosis	0.000139	0.000658	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—multiple sclerosis	0.000139	0.000654	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—multiple sclerosis	0.000138	0.000651	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—multiple sclerosis	0.000137	0.000648	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—multiple sclerosis	0.000137	0.000648	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—multiple sclerosis	0.000137	0.000645	CcSEcCtD
Buprenorphine—Vomiting—Mitoxantrone—multiple sclerosis	0.000137	0.000644	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—multiple sclerosis	0.000136	0.000642	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—multiple sclerosis	0.000136	0.000642	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000136	0.000641	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—multiple sclerosis	0.000136	0.000639	CcSEcCtD
Buprenorphine—Rash—Mitoxantrone—multiple sclerosis	0.000136	0.000639	CcSEcCtD
Buprenorphine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000135	0.000639	CcSEcCtD
Buprenorphine—Chills—Methotrexate—multiple sclerosis	0.000135	0.000638	CcSEcCtD
Buprenorphine—Headache—Mitoxantrone—multiple sclerosis	0.000135	0.000635	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000134	0.000632	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000134	0.000632	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—multiple sclerosis	0.000134	0.00063	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—multiple sclerosis	0.000134	0.00063	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000134	0.00063	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000133	0.000629	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—multiple sclerosis	0.000133	0.000628	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—multiple sclerosis	0.000133	0.000628	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—multiple sclerosis	0.000133	0.000628	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000133	0.000626	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000132	0.000624	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000132	0.000623	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—multiple sclerosis	0.000132	0.000623	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—multiple sclerosis	0.000132	0.000623	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—multiple sclerosis	0.000132	0.000623	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—multiple sclerosis	0.000131	0.000619	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—multiple sclerosis	0.000131	0.000619	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00013	0.000613	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00013	0.000611	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—multiple sclerosis	0.00013	0.000611	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—multiple sclerosis	0.000129	0.000608	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—multiple sclerosis	0.000129	0.000606	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—multiple sclerosis	0.000128	0.000606	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000128	0.000605	CcSEcCtD
Buprenorphine—Oedema—Prednisone—multiple sclerosis	0.000128	0.000604	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000128	0.000604	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000128	0.000603	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000128	0.000603	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—multiple sclerosis	0.000128	0.000603	CcSEcCtD
Buprenorphine—Nausea—Mitoxantrone—multiple sclerosis	0.000128	0.000602	CcSEcCtD
Buprenorphine—CYP3A4—nervous system—multiple sclerosis	0.000128	0.00842	CbGeAlD
Buprenorphine—Infection—Prednisone—multiple sclerosis	0.000127	0.0006	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000127	0.000599	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000127	0.000599	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—multiple sclerosis	0.000127	0.000599	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—multiple sclerosis	0.000127	0.000598	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—multiple sclerosis	0.000127	0.000598	CcSEcCtD
Buprenorphine—Shock—Prednisone—multiple sclerosis	0.000126	0.000595	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—multiple sclerosis	0.000126	0.000593	CcSEcCtD
Buprenorphine—Pain—Betamethasone—multiple sclerosis	0.000126	0.000593	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—multiple sclerosis	0.000126	0.000593	CcSEcCtD
Buprenorphine—CYP2D6—nervous system—multiple sclerosis	0.000126	0.00828	CbGeAlD
Buprenorphine—Tachycardia—Prednisone—multiple sclerosis	0.000125	0.00059	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—multiple sclerosis	0.000124	0.000587	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000124	0.000584	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—multiple sclerosis	0.000124	0.000583	CcSEcCtD
Buprenorphine—CYP3A4—central nervous system—multiple sclerosis	0.000123	0.00811	CbGeAlD
Buprenorphine—Anorexia—Prednisone—multiple sclerosis	0.000122	0.000576	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000122	0.000574	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000121	0.000572	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000121	0.000572	CcSEcCtD
Buprenorphine—CYP2D6—central nervous system—multiple sclerosis	0.000121	0.00798	CbGeAlD
Buprenorphine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00012	0.000567	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00012	0.000567	CcSEcCtD
Buprenorphine—ABCB1—medulla oblongata—multiple sclerosis	0.00012	0.00793	CbGeAlD
Buprenorphine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000119	0.000563	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000119	0.000562	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—multiple sclerosis	0.000118	0.000558	CcSEcCtD
Buprenorphine—CYP2D6—cerebellum—multiple sclerosis	0.000118	0.0078	CbGeAlD
Buprenorphine—Vertigo—Methotrexate—multiple sclerosis	0.000118	0.000556	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—multiple sclerosis	0.000117	0.000551	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—multiple sclerosis	0.000117	0.000551	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000117	0.000551	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—multiple sclerosis	0.000117	0.00055	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—multiple sclerosis	0.000116	0.000549	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—multiple sclerosis	0.000116	0.000549	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000116	0.000549	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—multiple sclerosis	0.000116	0.000549	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000116	0.000549	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—multiple sclerosis	0.000116	0.000547	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—multiple sclerosis	0.000116	0.000547	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—multiple sclerosis	0.000115	0.000543	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—multiple sclerosis	0.000115	0.000541	CcSEcCtD
Buprenorphine—Cough—Methotrexate—multiple sclerosis	0.000114	0.00054	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—multiple sclerosis	0.000114	0.00054	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—multiple sclerosis	0.000114	0.000536	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—multiple sclerosis	0.000113	0.000532	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—multiple sclerosis	0.000112	0.000527	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—multiple sclerosis	0.000112	0.000527	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—multiple sclerosis	0.000112	0.000527	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—multiple sclerosis	0.000111	0.000525	CcSEcCtD
Buprenorphine—Rash—Prednisolone—multiple sclerosis	0.000111	0.000524	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—multiple sclerosis	0.000111	0.000524	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000111	0.000523	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000111	0.000522	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—multiple sclerosis	0.00011	0.000521	CcSEcCtD
Buprenorphine—Headache—Prednisolone—multiple sclerosis	0.00011	0.000521	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—multiple sclerosis	0.00011	0.000521	CcSEcCtD
Buprenorphine—ABCB1—midbrain—multiple sclerosis	0.00011	0.00725	CbGeAlD
Buprenorphine—Constipation—Prednisone—multiple sclerosis	0.00011	0.000517	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—multiple sclerosis	0.000108	0.000509	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—multiple sclerosis	0.000107	0.000506	CcSEcCtD
Buprenorphine—ABCB1—spinal cord—multiple sclerosis	0.000107	0.00707	CbGeAlD
Buprenorphine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000107	0.000505	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.000505	CcSEcCtD
Buprenorphine—Infection—Methotrexate—multiple sclerosis	0.000106	0.000502	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—multiple sclerosis	0.000106	0.000498	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—multiple sclerosis	0.000106	0.000498	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—multiple sclerosis	0.000106	0.000498	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000105	0.000495	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000105	0.000494	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—multiple sclerosis	0.000105	0.000494	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—multiple sclerosis	0.000104	0.000491	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—multiple sclerosis	0.000104	0.000491	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—multiple sclerosis	0.000104	0.000491	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000104	0.000488	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—multiple sclerosis	0.000103	0.000486	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—multiple sclerosis	0.000103	0.000485	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—multiple sclerosis	0.000102	0.000482	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—multiple sclerosis	0.000102	0.000482	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—multiple sclerosis	0.000102	0.000481	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—multiple sclerosis	0.000102	0.000481	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000102	0.000481	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—multiple sclerosis	0.000102	0.00048	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—multiple sclerosis	0.000102	0.000479	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—multiple sclerosis	0.000101	0.000478	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—multiple sclerosis	0.000101	0.000478	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—multiple sclerosis	0.000101	0.000478	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000101	0.000475	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—multiple sclerosis	0.000101	0.000475	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—multiple sclerosis	0.0001	0.000472	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.76e-05	0.00046	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—multiple sclerosis	9.73e-05	0.000459	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—multiple sclerosis	9.73e-05	0.000459	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—multiple sclerosis	9.69e-05	0.000457	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—multiple sclerosis	9.63e-05	0.000454	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—multiple sclerosis	9.62e-05	0.000453	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—multiple sclerosis	9.61e-05	0.000453	CcSEcCtD
Buprenorphine—CYP2D6—brain—multiple sclerosis	9.59e-05	0.00633	CbGeAlD
Buprenorphine—Dyspnoea—Methotrexate—multiple sclerosis	9.55e-05	0.00045	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—multiple sclerosis	9.52e-05	0.000449	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—multiple sclerosis	9.44e-05	0.000445	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—multiple sclerosis	9.43e-05	0.000445	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—multiple sclerosis	9.36e-05	0.000441	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—multiple sclerosis	9.36e-05	0.000441	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—multiple sclerosis	9.31e-05	0.000439	CcSEcCtD
Buprenorphine—Rash—Betamethasone—multiple sclerosis	9.28e-05	0.000438	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—multiple sclerosis	9.28e-05	0.000438	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—multiple sclerosis	9.27e-05	0.000437	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—multiple sclerosis	9.27e-05	0.000437	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.25e-05	0.000436	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—multiple sclerosis	9.23e-05	0.000435	CcSEcCtD
Buprenorphine—Headache—Betamethasone—multiple sclerosis	9.22e-05	0.000435	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—multiple sclerosis	9.22e-05	0.000435	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—multiple sclerosis	9.19e-05	0.000434	CcSEcCtD
Buprenorphine—Pain—Methotrexate—multiple sclerosis	9.16e-05	0.000432	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—multiple sclerosis	9.07e-05	0.000428	CcSEcCtD
Buprenorphine—ABCB1—nervous system—multiple sclerosis	9.03e-05	0.00596	CbGeAlD
Buprenorphine—Feeling abnormal—Methotrexate—multiple sclerosis	8.82e-05	0.000416	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—multiple sclerosis	8.77e-05	0.000413	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.76e-05	0.000413	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—multiple sclerosis	8.74e-05	0.000412	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—multiple sclerosis	8.74e-05	0.000412	CcSEcCtD
Buprenorphine—ABCB1—central nervous system—multiple sclerosis	8.69e-05	0.00574	CbGeAlD
Buprenorphine—Urticaria—Methotrexate—multiple sclerosis	8.51e-05	0.000401	CcSEcCtD
Buprenorphine—ABCB1—cerebellum—multiple sclerosis	8.5e-05	0.00561	CbGeAlD
Buprenorphine—Dizziness—Prednisone—multiple sclerosis	8.47e-05	0.0004	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—multiple sclerosis	8.47e-05	0.000399	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—multiple sclerosis	8.47e-05	0.000399	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—multiple sclerosis	8.15e-05	0.000384	CcSEcCtD
Buprenorphine—Rash—Prednisone—multiple sclerosis	8.08e-05	0.000381	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—multiple sclerosis	8.07e-05	0.000381	CcSEcCtD
Buprenorphine—Headache—Prednisone—multiple sclerosis	8.03e-05	0.000379	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—multiple sclerosis	7.89e-05	0.000372	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—multiple sclerosis	7.68e-05	0.000362	CcSEcCtD
Buprenorphine—Nausea—Prednisone—multiple sclerosis	7.61e-05	0.000359	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—multiple sclerosis	7.58e-05	0.000357	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—multiple sclerosis	7.33e-05	0.000346	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—multiple sclerosis	7.08e-05	0.000334	CcSEcCtD
Buprenorphine—ABCB1—brain—multiple sclerosis	6.9e-05	0.00456	CbGeAlD
Buprenorphine—Vomiting—Methotrexate—multiple sclerosis	6.81e-05	0.000321	CcSEcCtD
Buprenorphine—Rash—Methotrexate—multiple sclerosis	6.75e-05	0.000318	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—multiple sclerosis	6.75e-05	0.000318	CcSEcCtD
Buprenorphine—Headache—Methotrexate—multiple sclerosis	6.71e-05	0.000316	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—multiple sclerosis	6.36e-05	0.0003	CcSEcCtD
Buprenorphine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.28e-05	0.000277	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	3.23e-05	0.000273	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	3.22e-05	0.000271	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	3.21e-05	0.00027	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.19e-05	0.000269	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.17e-05	0.000267	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.16e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—POMC—multiple sclerosis	3.15e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	3.12e-05	0.000263	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	3.09e-05	0.000261	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCL2—multiple sclerosis	3.08e-05	0.00026	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.08e-05	0.00026	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	3.07e-05	0.000259	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	3.07e-05	0.000259	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.07e-05	0.000258	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.06e-05	0.000257	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.02e-05	0.000255	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—MAPK1—multiple sclerosis	3.02e-05	0.000254	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.01e-05	0.000254	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—BCHE—multiple sclerosis	2.98e-05	0.000251	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	2.95e-05	0.000249	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	2.91e-05	0.000246	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	2.87e-05	0.000242	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.85e-05	0.00024	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.85e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	2.84e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	2.84e-05	0.000239	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SRM—multiple sclerosis	2.82e-05	0.000237	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	2.81e-05	0.000237	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TYK2—multiple sclerosis	2.8e-05	0.000236	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PGR—multiple sclerosis	2.8e-05	0.000236	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.79e-05	0.000235	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	2.78e-05	0.000235	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.77e-05	0.000234	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	2.75e-05	0.000231	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.74e-05	0.000231	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD28—multiple sclerosis	2.72e-05	0.000229	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	2.67e-05	0.000225	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	2.64e-05	0.000222	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.61e-05	0.00022	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.61e-05	0.00022	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	2.59e-05	0.000218	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	2.55e-05	0.000215	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.55e-05	0.000215	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.55e-05	0.000215	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	2.52e-05	0.000212	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	2.51e-05	0.000211	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.5e-05	0.00021	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.5e-05	0.00021	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	2.49e-05	0.00021	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.49e-05	0.00021	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.49e-05	0.00021	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.49e-05	0.00021	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	2.47e-05	0.000208	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PGR—multiple sclerosis	2.46e-05	0.000207	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	2.41e-05	0.000203	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	2.4e-05	0.000202	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD28—multiple sclerosis	2.39e-05	0.000201	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	2.38e-05	0.0002	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—BCHE—multiple sclerosis	2.36e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.34e-05	0.000197	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.34e-05	0.000197	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.34e-05	0.000197	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	2.34e-05	0.000197	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.33e-05	0.000196	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2—multiple sclerosis	2.33e-05	0.000196	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.32e-05	0.000196	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.32e-05	0.000196	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—multiple sclerosis	2.32e-05	0.000195	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	2.28e-05	0.000192	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.27e-05	0.000192	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.27e-05	0.000191	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	2.23e-05	0.000188	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	2.22e-05	0.000187	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—multiple sclerosis	2.21e-05	0.000186	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	2.2e-05	0.000185	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	2.19e-05	0.000184	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.17e-05	0.000183	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.16e-05	0.000182	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	2.16e-05	0.000182	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.16e-05	0.000182	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.14e-05	0.000181	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.13e-05	0.000179	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.12e-05	0.000179	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.11e-05	0.000178	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PGR—multiple sclerosis	2.08e-05	0.000175	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.03e-05	0.000171	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	2.02e-05	0.00017	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD28—multiple sclerosis	2.02e-05	0.00017	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.02e-05	0.00017	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.01e-05	0.00017	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—BCHE—multiple sclerosis	2e-05	0.000169	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	2e-05	0.000168	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.98e-05	0.000167	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.98e-05	0.000167	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.98e-05	0.000167	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	1.98e-05	0.000167	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—STAT3—multiple sclerosis	1.96e-05	0.000165	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	1.95e-05	0.000165	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	1.95e-05	0.000164	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD86—multiple sclerosis	1.94e-05	0.000164	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.94e-05	0.000163	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.93e-05	0.000163	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	1.91e-05	0.000161	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.88e-05	0.000159	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.86e-05	0.000157	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	1.85e-05	0.000156	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	1.83e-05	0.000154	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MYC—multiple sclerosis	1.82e-05	0.000154	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.82e-05	0.000153	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—multiple sclerosis	1.82e-05	0.000153	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.82e-05	0.000153	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000151	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MAPK1—multiple sclerosis	1.78e-05	0.00015	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.00015	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	1.77e-05	0.000149	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	1.77e-05	0.000149	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.76e-05	0.000148	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.74e-05	0.000147	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.73e-05	0.000146	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	1.72e-05	0.000145	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD86—multiple sclerosis	1.7e-05	0.000143	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.7e-05	0.000143	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	1.7e-05	0.000143	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	1.69e-05	0.000142	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	1.68e-05	0.000142	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.68e-05	0.000141	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	1.68e-05	0.000141	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.65e-05	0.000139	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.64e-05	0.000139	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	1.63e-05	0.000137	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.62e-05	0.000136	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APOE—multiple sclerosis	1.57e-05	0.000132	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	1.55e-05	0.000131	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—POMC—multiple sclerosis	1.54e-05	0.00013	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.53e-05	0.000129	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.53e-05	0.000129	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	1.51e-05	0.000127	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.5e-05	0.000127	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.5e-05	0.000126	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.5e-05	0.000126	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	1.49e-05	0.000125	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	1.48e-05	0.000124	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-05	0.000121	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD86—multiple sclerosis	1.44e-05	0.000121	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000121	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—APOE—multiple sclerosis	1.42e-05	0.00012	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	1.42e-05	0.000119	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD80—multiple sclerosis	1.42e-05	0.000119	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000118	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.4e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.37e-05	0.000116	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOE—multiple sclerosis	1.37e-05	0.000116	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—multiple sclerosis	1.37e-05	0.000115	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.37e-05	0.000115	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—multiple sclerosis	1.35e-05	0.000113	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	1.32e-05	0.000111	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.31e-05	0.000111	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	1.31e-05	0.00011	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.29e-05	0.000109	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.29e-05	0.000108	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	1.28e-05	0.000107	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.26e-05	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	1.25e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.000105	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD80—multiple sclerosis	1.24e-05	0.000105	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—multiple sclerosis	1.22e-05	0.000103	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	1.2e-05	0.000101	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—multiple sclerosis	1.19e-05	0.000101	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—multiple sclerosis	1.18e-05	9.94e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.17e-05	9.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.17e-05	9.89e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.17e-05	9.83e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.16e-05	9.78e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	9.78e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	9.73e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	1.13e-05	9.52e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—multiple sclerosis	1.11e-05	9.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.11e-05	9.34e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—multiple sclerosis	1.09e-05	9.22e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.09e-05	9.17e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.08e-05	9.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.07e-05	9.01e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	8.84e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	1.05e-05	8.83e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—multiple sclerosis	1.03e-05	8.72e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—multiple sclerosis	1.03e-05	8.64e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.02e-05	8.59e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.01e-05	8.52e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1e-05	8.45e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—multiple sclerosis	9.97e-06	8.4e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—multiple sclerosis	9.95e-06	8.38e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	9.9e-06	8.34e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	9.75e-06	8.22e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	9.54e-06	8.04e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—multiple sclerosis	9.43e-06	7.95e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	9.41e-06	7.93e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—multiple sclerosis	9.4e-06	7.92e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—multiple sclerosis	9.35e-06	7.88e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.14e-06	7.7e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	8.86e-06	7.46e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—multiple sclerosis	8.72e-06	7.35e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	8.68e-06	7.31e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.64e-06	7.28e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—multiple sclerosis	8.63e-06	7.27e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—multiple sclerosis	8.57e-06	7.22e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	8.37e-06	7.05e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	8.25e-06	6.95e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MYC—multiple sclerosis	7.78e-06	6.55e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	7.76e-06	6.54e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	7.61e-06	6.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—multiple sclerosis	7.47e-06	6.3e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—multiple sclerosis	7.41e-06	6.25e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—multiple sclerosis	7.37e-06	6.21e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	7.34e-06	6.18e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	7.33e-06	6.18e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	6.98e-06	5.88e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MYC—multiple sclerosis	6.82e-06	5.75e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	6.8e-06	5.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—multiple sclerosis	6.76e-06	5.69e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	6.67e-06	5.62e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—multiple sclerosis	6.67e-06	5.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.67e-06	5.62e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—multiple sclerosis	6.51e-06	5.49e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—multiple sclerosis	6.42e-06	5.41e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	6.2e-06	5.23e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—multiple sclerosis	6.14e-06	5.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—multiple sclerosis	6.08e-06	5.13e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—multiple sclerosis	5.85e-06	4.93e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—multiple sclerosis	5.85e-06	4.93e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MYC—multiple sclerosis	5.76e-06	4.86e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	5.75e-06	4.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—multiple sclerosis	5.73e-06	4.83e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	5.64e-06	4.75e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—multiple sclerosis	5.59e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—multiple sclerosis	5.27e-06	4.44e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—multiple sclerosis	5.23e-06	4.4e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—multiple sclerosis	5.22e-06	4.4e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—multiple sclerosis	5.2e-06	4.38e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—multiple sclerosis	5.13e-06	4.32e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—multiple sclerosis	5.1e-06	4.3e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.81e-06	4.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—multiple sclerosis	4.76e-06	4.01e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—multiple sclerosis	4.47e-06	3.76e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—multiple sclerosis	4.33e-06	3.65e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—multiple sclerosis	4.07e-06	3.43e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.01e-06	3.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.45e-06	2.9e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.14e-06	2.65e-05	CbGpPWpGaD
